Myelogenous Leukemia

• CLINICAL_TRIALS trial_result · 2011-04-14
  Clinical Trial Update: Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan [Phase 1, Phase 2]

  This update notes the completion of a Phase 1/2 trial of BMS-354825 (dasatinib) in Japanese patients with chronic myelogenous leukemia who a…

• CLINICAL_TRIALS trial_result · 2010-12-14
  Clinical Trial Update: Rollover Study of BMS-354825 in Patients With CML and Ph+ALL [Phase 1, Phase 2]

  Rollover study of BMS-354825 (dasatinib) in patients with chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblas…

• CLINICAL_TRIALS trial_result · 2010-04-02
  Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]

  Phase 2 clinical trial evaluating combination chemotherapy followed by peripheral stem cell transplantation for chronic myelogenous leukemia…

• CLINICAL_TRIALS trial_result · 2010-04-02
  Clinical Trial Update: Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]

  A Phase 2 clinical trial evaluating chemotherapy followed by peripheral stem cell transplantation and biological therapy for chronic myeloge…

• CLINICAL_TRIALS trial_result · 2009-08-27
  Clinical Trial Update: Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion [Phase 2, Phase 3]

  Phase 2/3 clinical trial evaluating allogeneic stem cell transplantation with partial T cell depletion in chronic myelogenous leukemia; the …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2009-01-29
  Clinical Trial Update: Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]

  This document reports a Phase 3 clinical trial evaluating haploidentical hematopoietic stem cell transplantation in patients with hematologi…